Cleared Special

ROCHE DIAGNOSTICS TINA-QUANT IGA GEN.2

K040435 · Roche Diagnostics Corp. · Immunology
Mar 2004
Decision
20d
Days
Class 2
Risk

About This 510(k) Submission

K040435 is an FDA 510(k) clearance for the ROCHE DIAGNOSTICS TINA-QUANT IGA GEN.2, a Iga, Antigen, Antiserum, Control (Class II — Special Controls, product code CZP), submitted by Roche Diagnostics Corp. (Indianapolos, US). The FDA issued a Cleared decision on March 10, 2004, 20 days after receiving the submission on February 19, 2004. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5510.

Submission Details

510(k) Number K040435 FDA.gov
FDA Decision Cleared SESE
Date Received February 19, 2004
Decision Date March 10, 2004
Days to Decision 20 days
Submission Type Special
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code CZP — Iga, Antigen, Antiserum, Control
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.5510

Similar Devices — CZP Iga, Antigen, Antiserum, Control

All 53
Yumizen C1200 Immunoglobulin A, Yumizen C1200 Immunoglobulin G, Yumizen C1200 Immunoglobulin M
K193525 · HORIBA ABX SAS · Jun 2020
IMMAGE SYSTEMS LOW CONCENTRATION IMMUNOGLOBULIN A REAGENT
K060130 · Beckman Coulter, Inc. · Feb 2006
N LATEX IGA
K024038 · Dade Behring, Inc. · Feb 2003
WAKO IGA II-HA, IMMUNOGLOBULIN CALIBRATOR SET, IMMUNOGLOBULIN STANDRAD
K993927 · Wako Chemicals USA, Inc. · Jan 2000
IGA
K983359 · Abbott Laboratories · Nov 1998
QUANTEX IGA
K962200 · Instrumentation Laboratory CO · Sep 1996